Prime Capital Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,868
| Closed | -$236K | – | 916 |
|
|
2024
Q2 | $236K | Sell |
2,868
-2,145
| -43% | -$177K | ﹤0.01% | 802 |
|
|
2024
Q1 | $438K | Sell |
5,013
-3,957
| -44% | -$346K | 0.01% | 654 |
|
|
2023
Q4 | $865K | Sell |
8,970
-241
| -3% | -$23.2K | 0.01% | 458 |
|
|
2023
Q3 | $815K | Buy |
9,211
+2,204
| +31% | +$195K | 0.02% | 377 |
|
|
2023
Q2 | $607K | Buy |
7,007
+200
| +3% | +$17.3K | 0.01% | 438 |
|
|
2023
Q1 | $662K | Buy |
+6,807
| New | +$662K | 0.03% | 302 |
|